Cardinal Health (CAH) – Analysts’ Weekly Ratings Changes

Several analysts have recently updated their ratings and price targets for Cardinal Health (NYSE: CAH):

• 1/14/2026 – Cardinal Health was given a new $250.00 price target on by analysts at Robert W. Baird.
• 1/13/2026 – Cardinal Health was given a new $240.00 price target on by analysts at Leerink Partners.
• 1/12/2026 – Cardinal Health was given a new $222.00 price target on by analysts at Mizuho.
• 1/9/2026 – Cardinal Health was upgraded by analysts at Citigroup Inc. from a “neutral” rating to a “buy” rating. They now have a $244.00 price target on the stock, up previously from $190.00.
• 12/8/2025 – Cardinal Health is now covered by analysts at Barclays PLC. They set an “overweight” rating and a $243.00 price target on the stock.
• 12/8/2025 – Cardinal Health is now covered by analysts at Barclays PLC. They set an “overweight” rating and a $243.00 price target on the stock.
• 11/18/2025 – Cardinal Health had its price target raised by analysts at Deutsche Bank Aktiengesellschaft from $195.00 to $208.00. They now have a “hold” rating on the stock.
• 11/17/2025 – Cardinal Health had its price target raised by analysts at Leerink Partners from $211.00 to $230.00. They now have an “outperform” rating on the stock.

Cardinal Health Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Thursday, January 15th. Stockholders of record on Friday, January 2nd will be given a dividend of $0.5107 per share. This represents a $2.04 dividend on an annualized basis and a dividend yield of 1.0%. The ex-dividend date of this dividend is Friday, January 2nd. Cardinal Health’s payout ratio is presently 30.77%.

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.